| Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers N Mars, JT Koskela, P Ripatti, TTJ Kiiskinen, AS Havulinna, JV Lindbohm, ... Nature medicine 26 (4), 549-557, 2020 | 386 | 2020 |
| Genetic architecture of human plasma lipidome and its link to cardiovascular disease R Tabassum, JT Rämö, P Ripatti, JT Koskela, M Kurki, J Karjalainen, ... Nature communications 10 (1), 4329, 2019 | 167 | 2019 |
| Polygenic hyperlipidemias and coronary artery disease risk P Ripatti, JT Rämö, NJ Mars, Y Fu, J Lin, S Söderlund, C Benner, ... Circulation: Genomic and Precision Medicine 13 (4), e002725, 2020 | 100 | 2020 |
| How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study E Widén, N Junna, S Ruotsalainen, I Surakka, N Mars, P Ripatti, ... Circulation: Genomic and Precision Medicine 15 (2), e003459, 2022 | 92 | 2022 |
| Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans J Borén, M Adiels, E Björnson, N Matikainen, S Söderlund, J Rämö, ... JCI insight 5 (24), 2020 | 68 | 2020 |
| The Contribution of GWAS Loci in Familial Dyslipidemias P Ripatti, JT Rämö, S Söderlund, I Surakka, N Matikainen, M Pirinen, ... PLoS Genet 12 (5), e1006078, 2016 | 60 | 2016 |
| Coronary artery disease risk and lipidomic profiles are similar in hyperlipidemias with family history and population‐ascertained hyperlipidemias JT Rämö, P Ripatti, R Tabassum, S Söderlund, N Matikainen, MJ Gerl, ... Journal of the American Heart Association 8 (13), e012415, 2019 | 36 | 2019 |
| Genomic prediction of alcohol-related morbidity and mortality T Kiiskinen, NJ Mars, T Palviainen, J Koskela, JT Rämö, P Ripatti, ... Translational Psychiatry 10 (1), 23, 2020 | 31 | 2020 |
| Communicating polygenic and non-genetic risk for atherosclerotic cardiovascular disease-An observational follow-up study E Widén, N Junna, S Ruotsalainen, I Surakka, N Mars, P Ripatti, ... MedRxiv, 2020.09. 18.20197137, 2020 | 20 | 2020 |
| Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans J Borén, M Adiels, E Björnson, N Matikainen, S Söderlund, J Rämö, ... Journal of internal medicine 291 (2), 218-223, 2022 | 15 | 2022 |
| Genetics of human plasma lipidome: Understanding lipid metabolism and its link to diseases beyond traditional lipids R Tabassum, JT Rämö, P Ripatti, JT Koskela, M Kurki, J Karjalainen, ... BioRxiv, 457960, 2018 | 12 | 2018 |
| Integration of biomarker polygenic risk score improves prediction of coronary heart disease J Lin, N Mars, Y Fu, P Ripatti, FinnGen study, T Kiiskinen, T Tukiainen, ... Basic to Translational Science 8 (12), 1489-1499, 2023 | 9 | 2023 |
| Polygenic and clinical risk scores and their impact on age at onset of cardiometabolic diseases and common cancers NJ Mars, JT Koskela, P Ripatti, TTJ Kiiskinen, AS Havulinna, ... bioRxiv, 727057, 2019 | 8 | 2019 |
| Multiparametric platform for profiling lipid trafficking in human leukocytes SG Pfisterer, I Brock, K Kanerva, I Hlushchenko, L Paavolainen, P Ripatti, ... Cell Reports Methods 2 (2), 2022 | 7 | 2022 |
| Genetic architecture of human plasma lipidome and its link to cardiovascular disease. Nat Commun. 2019; 10 (1): 4329 R Tabassum, JT Ramo, P Ripatti, JT Koskela, M Kurki, J Karjalainen Epub 2019/09/26. doi: 10.1038/s41467-019-11954-8. PubMed PMID: 31551469, 0 | 3 | |
| Novel Finnish-enriched variants causing severe hypercholesterolemia and their clinical impact on coronary artery disease N Junna, S Ruotsalainen, P Ripatti, S Ripatti, E Widén Atherosclerosis 386, 117327, 2023 | 2 | 2023 |
| Integration of biomarker polygenic risk score improves prediction of coronary heart disease in UK Biobank and FinnGen J Lin, N Mars, Y Fu, P Ripatti, T Kiiskinen, FinnGen, T Tukiainen, S Ripatti, ... medRxiv, 2022.08. 22.22279057, 2022 | 2 | 2022 |
| Polygenic risk score of alcohol consumption predicts alcohol-related morbidity and all-cause mortality T Kiiskinen, NJ Mars, T Palviainen, J Koskela, P Ripatti, JT Rämö, ... bioRxiv, 652396, 2019 | 2 | 2019 |
| Polygenic hyperlipidemia and coronary artery disease risk P Ripatti, J Rämö, S Söderlund, I Surakka, N Matikainen, V Salomaa, ... Atherosclerosis 263, e4, 2017 | 2 | 2017 |
| Polygenic hyperlipidemias and coronary artery disease risk P Ripatti, JT Rämö, NJ Mars, S Söderlund, C Benner, I Surakka, ... bioRxiv, 735167, 2019 | 1 | 2019 |
Aarno PalotieFIMM, Broad Institute, UCLA, University of Helsinki, Sanger InstituteDirección de correo verificada de helsinki.fi
